The global burden of disease attributable to high body mass index in 195 countries and territories, 19902017: an analysis of the Global Burden of Disease Study
This mechanism represents genuine anti-aging action at the molecular core
This study investigated the glutathione antioxidant system (total glutathione, reduced glutathione, glutathione peroxidase) in experimental diabetic rats treated orally with magnesium
81 WagnerU.EdwardsR.DixonD
The company bets this approach could lead to more significant and sustained weight loss compared to mono-agonist drugs

Theoretical potential benefits (currently unproven for rheumatoid arthritis and not studied at microdose levels): Possible anti-inflammatory effects through modulation of immune pathways Weight reduction, which may indirectly benefit joint symptoms in overweight patients Cardiovascular risk reduction, relevant given increased cardiovascular disease risk in rheumatoid arthritis (established in type 2 diabetes populations at therapeutic doses only) [28] Improved metabolic parameters in patients with concurrent metabolic syndrome Known adverse effects of GLP-1 receptor agonists at standard doses include: Gastrointestinal symptoms : nausea, vomiting, diarrhoea, constipation, and abdominal discomfort (very common, affecting more than 1 in 10 patients) Hypoglycaemia : particularly when used with other glucose-lowering medications Injection site reactions : erythema, pruritus, or nodules Pancreatitis : rare but serious, requiring immediate medical attention if severe abdominal pain develops Gallbladder disease : increased risk of cholelithiasis and cholecystitis Thyroid effects : thyroid C-cell tumours observed in rodents
